PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine and Pathology, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.\', \'Department of Quantitative Health Sciences, Mayo Clinicgrid.66875.3a, Jacksonville, Florida, USA.\', \'Department of Quantitative Health Sciences, Mayo Clinicgrid.66875.3a, Scottsdale, Arizona, USA.\', \'Advanced Diagnostics Laboratory, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.\', \'Department of Anesthesiology and Perioperative Medicine, Mayo Clinicgrid.66875.3a Rochester, Minnesota, USA.\', \'School of Life Sciences, Arizona State Universitygrid.215654.1, Tempe, Arizona, USA.\', \'Axim Biotechnologies Inc., San Diego, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JCM.01231-21
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34166066
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all